Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection FractionMichael E. Nassif, John M. Cox, Michael Pursley et al.|Circulation|2019Cited by 427
Abnormalities of Mitochondrial Dynamics in the Failing Heart: Normalization Following Long-Term Therapy with ElamipretideHani N. Sabbah, David E. Lanfear|Cardiovascular Drugs and Therapy|2018Cited by 86
Prognostic Value of Circulating microRNAs on Heart Failure-Related Morbidity and Mortality in Two Large Diverse Cohorts of General Heart Failure PatientsAntoni Bayés‐Genís, Yigal M. Pinto, David E. Lanfear et al.|European Journal of Heart Failure|2017Cited by 84
Heart Failure in the Era of Precision Medicine: A Scientific Statement From the American Heart AssociationSharon Cresci, Matthew J. Wolf, Naveen L. Pereira et al.|Circulation Genomic and Precision Medicine|2019Cited by 60
Extremes of body mass index do not impact mid-term survival after continuous-flow left ventricular assist device implantationRobert J. Brewer, Mark S. Slaughter, David E. Lanfear et al.|The Journal of Heart and Lung Transplantation|2012Cited by 60